Stem cell transplants offer long-term benefits for pediatric cancer patients receiving immunotherapy
Stem cell transplants offer long-term benefits for pediatric cancer patients receiving immunotherapy Apr 1 2021 Children and young adults who receive CAR T-cell therapy for the most common childhood cancer - acute lymphoblastic leukemia - suffer remarkably fewer relapses and are far more likely to survive when the treatment is paired with a subsequent stem cell transplant, a new study finds. Daniel "Trey" Lee is conducting pioneering clinical research in the battle against childhood cancer. Image Credit: UVA Health The research, with an average follow up of nearly five years, suggests that st...